Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
CK-586 by Cytokinetics for Diastolic Heart Failure (HFpEF): Likelihood of Approval
CK-586 is under clinical development by Cytokinetics and currently in Phase I for Diastolic Heart Failure (HFpEF). According to GlobalData,...